Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer

NCT00983580 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

107

Enrollment

NIH

Sponsor class

Conditions

Adenomatous Polyp

Interventions

DRUG: Aspirin
DRUG: Eflornithine
OTHER: Laboratory Biomarker Analysis
OTHER: Placebo
OTHER: Telephone-Based Intervention

Sponsor

National Cancer Institute (NCI)